Description: Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Home Page: www.diaceutics.com
Building Two
Belfast,
BT9 6GW
United Kingdom
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Peter Keeling | Founder & Executive Chairman |
| Mr. Ryan Keeling | CEO & Director |
| Mr. Nicholas Stewart Roberts | CFO & Director |
| Ken Ruppel | Vice President of Scientific & Medical Services |
| Ms. Gillian Shaw | General Counsel |
| Amie McNiece | Vice President of Marketing |
| Marianna Sciortino | Interim VP of Sales |
| Ms. Sandra Blake | Chief People Officer |
| Mr. Jordan Russell Clark | Chief Data Officer? & Executive Director |
| Ms. Susanne Munksted | Chief Precision Medicine Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 111.1111 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4421 |
| Price-to-Sales TTM: | 4.5561 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 184 |